BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Thapa SD, Hadid H, Usman M, Imam W, Hassan A, Schairer J, Jafri SM, Kaur N. Predictors of Thiopurine Treatment Failure in Biologic-Naïve Ulcerative Colitis Patients. Dig Dis Sci 2016;61:230-7. [PMID: 26511478 DOI: 10.1007/s10620-015-3864-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Kourkoulis P, Kapizioni C, Michalopoulos G, Andreou N, Papaconstantinou I, Karamanolis G, Gazouli M. Novel potential biomarkers for the diagnosis and monitoring of patients with ulcerative colitis. European Journal of Gastroenterology & Hepatology 2019;31:1173-83. [DOI: 10.1097/meg.0000000000001490] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Greenstein RJ, Cameron DW, Brown ST. A Data-Based Hypothesis Explicating Thiopurine Therapeutic Failure in Biologic-Naive UC. Dig Dis Sci 2017;62:282-3. [PMID: 27812848 DOI: 10.1007/s10620-016-4360-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
3 Barber GE, Hendler S, Choe M, Keyashian K, Lechner S, Limketkai BN, Limsui D. Thiopurine Monotherapy Is Effective in Maintenance of Mild-Moderate Inflammatory Bowel Disease. Dig Dis Sci 2021. [PMID: 33755823 DOI: 10.1007/s10620-021-06947-x] [Reference Citation Analysis]
4 Prieux-Klotz C, Nahon S, Amiot A, Sinayoko L, Galéano-Cassaz C, Chaussade S, Coriat R, Lahmek P, Abitbol V. Rate and Predictors of Mucosal Healing in Ulcerative Colitis Treated with Thiopurines: Results of a Multicentric Cohort Study. Dig Dis Sci 2017;62:473-80. [PMID: 27853898 DOI: 10.1007/s10620-016-4374-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
5 Zhang M, Bai X, Zhang H, You Y, Lv H, Li Y, Tan B, Li J, Xu H, Zheng W, Yang H, Qian J. The role of cytomegalovirus colitis on short- and long-term outcomes for patients with ulcerative colitis. Scand J Gastroenterol 2021;:1-8. [PMID: 34894997 DOI: 10.1080/00365521.2021.2006298] [Reference Citation Analysis]
6 Stevens TW, Matheeuwsen M, Lönnkvist MH, Parker CE, Wildenberg ME, Gecse KB, D’haens GR. Systematic review: predictive biomarkers of therapeutic response in inflammatory bowel disease-personalised medicine in its infancy. Aliment Pharmacol Ther 2018;48:1213-31. [DOI: 10.1111/apt.15033] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
7 Khan N, Patel D, Shah Y, Trivedi C, Yang YX. Albumin as a prognostic marker for ulcerative colitis. World J Gastroenterol 2017; 23(45): 8008-8016 [PMID: 29259376 DOI: 10.3748/wjg.v23.i45.8008] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
8 Khasawneh M, Spence AD, Addley J, Allen PB. The role of smoking and alcohol behaviour in the management of inflammatory bowel disease. Best Pract Res Clin Gastroenterol. 2017;31:553-559. [PMID: 29195675 DOI: 10.1016/j.bpg.2017.10.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]